214 related articles for article (PubMed ID: 24126059)
1. CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.
Mellor P; Deibert L; Calvert B; Bonham K; Carlsen SA; Anderson DH
Mol Cell Biol; 2013 Dec; 33(24):4985-95. PubMed ID: 24126059
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
3. Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
Mellor P; Kendall S; Smith S; Saxena A; Anderson DH
PLoS One; 2022; 17(7):e0271090. PubMed ID: 35802566
[TBL] [Abstract][Full Text] [Related]
4. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract][Full Text] [Related]
5. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.
Feng YX; Jin DX; Sokol ES; Reinhardt F; Miller DH; Gupta PB
Nat Commun; 2017 Oct; 8(1):1079. PubMed ID: 29057869
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.
Raiter A; Lipovetsky J; Hyman L; Mugami S; Ben-Zur T; Yerushalmi R
Front Oncol; 2020; 10():1500. PubMed ID: 33042795
[TBL] [Abstract][Full Text] [Related]
7. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
8. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
9. CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.
Denard B; Jiang S; Peng Y; Ye J
BMC Cancer; 2018 Aug; 18(1):813. PubMed ID: 30103710
[TBL] [Abstract][Full Text] [Related]
10. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.
Goodison S; Yuan J; Sloan D; Kim R; Li C; Popescu NC; Urquidi V
Cancer Res; 2005 Jul; 65(14):6042-53. PubMed ID: 16024604
[TBL] [Abstract][Full Text] [Related]
11. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
12. Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
Chander H; Brien CD; Truesdell P; Watt K; Meens J; Schick C; Germain D; Craig AW
Breast Cancer Res; 2014 Dec; 16(6):3413. PubMed ID: 25547174
[TBL] [Abstract][Full Text] [Related]
13. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
14. cAMP-Response Element-Binding 3-Like Protein 1 (CREB3L1) is Required for Decidualization and its Expression is Decreased in Women with Endometriosis.
Ahn JI; Yoo JY; Kim TH; Kim YI; Ferguson SD; Fazleabas AT; Young SL; Lessey BA; Ahn JY; Lim JM; Jeong JW
Curr Mol Med; 2016; 16(3):276-87. PubMed ID: 26917262
[TBL] [Abstract][Full Text] [Related]
15. Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein.
Shimizu A; Nakayama H; Wang P; König C; Akino T; Sandlund J; Coma S; Italiano JE; Mammoto A; Bielenberg DR; Klagsbrun M
J Biol Chem; 2013 Jan; 288(4):2210-22. PubMed ID: 23195957
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
17. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
18. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
19. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]